Nitric oxide and macrophage antiviral extrinsic activity

In this study we evaluated the relationship between nitric oxide (NO) and macrophage antiviral extrinsic activity. Macrophages activated by intraperitoneal injection of herpes simplex virus-2 (HSV-2), showed both extrinsic antiviral activity and high nitrite production in contrast to non-activated,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Benencia, F.
Otros Autores: Courreges, M.C
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1999
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 11916caa a22012257a 4500
001 PAPER-19480
003 AR-BaUEN
005 20230518205050.0
008 190411s1999 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0032720135 
024 7 |2 cas  |a Nitric Oxide, 10102-43-9; Nitrites; omega-N-Methylarginine, 17035-90-4 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a IMMUA 
100 1 |a Benencia, F. 
245 1 0 |a Nitric oxide and macrophage antiviral extrinsic activity 
260 |c 1999 
270 1 0 |m Benencia, F.; Laboratorio de Inmunoquimica, Departamento Quimica Biologica, Universidad de Buenos Aires, Ciudad Universitaria, (1428) Buenos Aires, Argentina 
506 |2 openaire  |e Política editorial 
504 |a Hayashi, K., Kurata, T., Morishima, T., Nassery, T., Analysis of the inhibitory effect of peritoneal macrophages on the spread of herpes simplex virus (1980) Infect Immun, 28, p. 350 
504 |a Sit, M.F., Tenney, D.J., Rothstein, J.L., Morahan, P.S., Effect of macrophage activation on resistance of mouse peritoneal macrophages to infection with herpes simplex virus types 1 and 2 (1988) J Gen Virol, 69, p. 1999 
504 |a Morahan, P.S., Morse, S., McGeorge, M., Macrophage extrinsic antiviral activity during herpes simplex virus infection (1980) J Gen Virol, 46, p. 291 
504 |a Ellerman-Eriksen, S., Autocrine secretion of interferon-α/β and tumour necrosis factor-α synergistically activates mouse macrophages after infection with herpes simplex virus type 2 (1993) J Gen Virol, 74, p. 2191 
504 |a Ellerman-Eriksen, S., Sommerlund, M., Mogensen, S.C., Differential sensitivity of macrophages from herpes simplex virus resistant and susceptible mice to respiratory burst priming by interferon-α/β (1989) J Gen Virol, 70, p. 2139 
504 |a Stohlman, S.A., Woodward, J.G., Frelinger, J.A., Macrophage antiviral activity: Extrinsic versus intrinsic activity (1982) Infect Immun, 36, p. 672 
504 |a Croen, K., Evidence for an antiviral effect of nitric oxide (1993) J Clin Invest, 91, p. 2446 
504 |a Taguchi, F., Yamada, A., Fujiwara, K., Resistance to highly virulent mouse hepatitis virus acquired by mice after low virulence infection: Enhanced antiviral activity of macrophages (1980) Infect Immun, 29, p. 42 
504 |a Karupiah, G., Xie, Q., Buller, R.M.L., Nathan, C., Duiarte, C., MacMicking, J.D., Inhibition of viral replication by interferon-γ-induced nitric oxide synthase (1993) Science, 261, p. 1445 
504 |a Nathan, C., Nitric oxide as a secretory product of mammalian cells (1992) FASEB J, 6, p. 3051 
504 |a Stuehr, D.J., Nathan, C.F., Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells (1989) J Exp Med, 5, p. 1543 
504 |a Ding, A.H., Nathan, C.F., Stuehr, D.J., Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages (1988) J Immunol, 141, p. 2407 
504 |a Rolph, M.S., Ramshaw, I.A., Rocket, K.A., Ruby, J., Coudn, W.B., Nitric oxide production is increased during murine vaccinia virus infection but may not be essential for virus clearance (1996) Virology, 217, p. 470 
504 |a Amaro, M.J., Bartolome, J., Pardo, M., Cotonat, T., Lopez-Farre, A., Carreno, V., Decreased nitric oxide production in chronic viral hepatitis B and C (1997) J Med Virol, 51, p. 326 
504 |a Lane, T.E., Paoletti, A.D., Buchmeier, M.J., Dissociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus (1997) J Virol, 71, p. 2202 
504 |a Lin, Y., Huang, Y., Ma, S., Inhibition of japanese encephalitis virus infection by nitric oxide: Antiviral effect of nitric oxide on RNA virus replication (1997) J Virol, 71, p. 5227 
504 |a Guillemard, E., Geniteau-Legendere, M., Kergot, R., Activity of nitric oxide-generating compounds against encephalomyocarditis virus (1996) Antimicrob Agents Chemother, 40, p. 1057 
504 |a Hiraoka, Y., Kishimoto, C., Takada, H., Nitric oxide and murine coxsackievirus B3 myocarditis: Aggravation of myocarditis by inhibition of nitric oxide synthase (1996) J Am Coll Cardiol, 28, p. 1610 
504 |a Lowenstein, C.H.J., Hill, S.L., Lafond-Walker, A., Nitric oxide inhibits viral replication in murine myocarditis (1996) J Clin Invest, 97, p. 1837 
504 |a Mikami, S., Kawashima, S., Kanazawa, K., Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3 (1996) Biochem Biophys Res Commun, 220, p. 983 
504 |a Pertile, T.L., An antiviral effect of nitric oxide: Inhibition of reovirus replication (1996) Avian Dis, 40, p. 342 
504 |a Akarid, K., Sinet, M., Desforges, B., Gougerot-Pocidalo, M.A., Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo (1995) J Virol, 69, p. 7001 
504 |a Bi, Z., Barna, M., Komatsu, T., Reiss, C.S., Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity (1995) J Virol, 69, p. 6466 
504 |a Bi, Z., Reiss, C.S., Inhibition of vesicular stomatitis virus infection by nitric oxide (1995) J Virol, 69, p. 2208 
504 |a Harris, N., Buller, M., Karupiah, G., Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication (1995) J Virol, 69, p. 910 
504 |a MacMicking, J., Xie, Q., Nathan, C., Nitric oxide and macrophage function (1997) Annu Rev Immunol, 15, p. 323 
504 |a Golstein, P., Blomgreen, H., Further evidence for autonomy of T cells mediating specific in vitro cytotoxicity efficiency of very small amounts of highly purified T cells (1973) Cell Immunol, 9, p. 127 
504 |a Sudo, K., Konno, K., Yokota, T., Shigeta, S., A sensitive assay system for screening antiviral compounds against herpes simplex virus type 1 and type 2 (1994) J Virol Methods, 49, p. 169 
504 |a Irie, H., Shimeld, C., Williams, N., Hill, T., Protection against ocular and cutaneous infection with herpes simplex virus type 1 by intragastric immunisation with live virus (1993) J Gen Virol, 74, p. 1357 
504 |a Babu, J.S., Thomas, J., Kanangat, S., Morrison, L.A., Knipe, D.M., Rouse, B.T., Viral replication is required for induction of ocular immunopathology by herpes simplex virus (1996) J Virol, 70, p. 101 
504 |a Baskin, H., Ellerman-Eriksen, S., Lovmand, J., Mogensen, S.C., Herpes simplex virus type 2 synergizes with interferon γ in the induction of nitric oxide production in mouse macrophages through autocrine secretion of tumour necrosis factor-α (1997) J Gen Virol, 78, p. 195 
504 |a Hirohashi, N., Richards, M., Morrison, D.C., Selective effects of serum on bacterial LPS-induced IL-6 and nitric oxide production in murine peritoneal macrophages (1996) J Endotox Res, 3, p. 395 
504 |a Pyo, S., Gangemi, J.D., Ghaffar, A., Mayer, E.P., Poly 1:C induced antiviral and cytotoxic activities are mediated by different mechanisms (1993) Int J Immunopharmacol, 15, p. 477 
504 |a Stuehr, D.J., Marletta, M.A., Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ (1987) J Immunol, 139, p. 518 
504 |a Park, E., Schuller-Levis, G., Jia, J., Quinn, M.R., Preactivation of RAW 264.7 cells to taurine chloramine attenuates subsequent production of nitric oxide and expression of iNOS mRNA. J (1997) Leukocyte Biol, 61, p. 161 
504 |a Wolff, D.J., Lubeskie, A., Li, C.H., Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cells treated with irreversible NO synthase inhibitors (1997) Arch Biochem Biophys, 338, p. 73 
504 |a Gotoh, T., Sonoki, T., Nagasaki, A., Terada, K., Takiguchi, M., Mori, M., Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line (1996) FEBS Lett, 395, p. 119 
504 |a Coffey, R.G., Yamamoto, Y., Snella, E., Pross, S., Tetrahydrocannabinol inhibition of macrophage nitric oxide production (1996) Biochem Pharmacol, 52, p. 743 
504 |a Cabral, G.A., Vazquez, R., Delta 9 tetrahydrocannanobiol suppresses macrophage extrinsic antiherpes activity (1992) Proc Soc Exp Biol Med, 199, p. 255 
504 |a Wildy, P., Gill, P.G., Rhodes, J., Newton, A., Inhibition of herpes simplex virus multiplication by activated macrophages: A role for arginase (1982) Infect Immun, 37, p. 40 
504 |a Hrabak, A., Bajor, T., Temesi, A., Meszaros, G., The inhibitory effect of nitrite, a stable product of nitric oxide (NO) formation, on arginase (1996) FEBS Lett, 390, p. 203 
520 3 |a In this study we evaluated the relationship between nitric oxide (NO) and macrophage antiviral extrinsic activity. Macrophages activated by intraperitoneal injection of herpes simplex virus-2 (HSV-2), showed both extrinsic antiviral activity and high nitrite production in contrast to non-activated, resident macrophages. The extrinsic antiviral activity was observed in cultures of Vero cells infected with HSV-1 and HSV-2. The NO inhibitor N-monomethyl-L-arginine acetate (L-NMA) impaired the antiviral activity of HSV-elicited macrophages. The effect was dose dependent and correlated with a reduction of nitrite in the culture media. The effect of L-NMA was reversed by the addition of L-arginine. These data indicate that NO could be responsible for the described activity. Furthermore, L-NMA treatment resulted in the aggravation of HSV1-induced keratitis in the mouse model, supporting a defensive role of NO in the pathogenesis of HSV-1 corneal infection.  |l eng 
593 |a Laboratorio de Inmunoquímica, Depto. Quimica Biológica, Universidad de Buenos Aires, Pabellón 11, (1428) Buenos Aires, Argentina 
690 1 0 |a N(G) METHYLARGININE 
690 1 0 |a NITRIC OXIDE 
690 1 0 |a ANIMAL CELL 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ARTICLE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a FEMALE 
690 1 0 |a HERPES SIMPLEX KERATITIS 
690 1 0 |a HERPES SIMPLEX VIRUS 1 
690 1 0 |a HERPES SIMPLEX VIRUS 2 
690 1 0 |a HOST RESISTANCE 
690 1 0 |a IMMUNOREACTIVITY 
690 1 0 |a INFECTION RESISTANCE 
690 1 0 |a MACROPHAGE ACTIVATION 
690 1 0 |a MOUSE 
690 1 0 |a NONHUMAN 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a SIGNAL TRANSDUCTION 
690 1 0 |a ANIMALS 
690 1 0 |a CERCOPITHECUS AETHIOPS 
690 1 0 |a DOSE-RESPONSE RELATIONSHIP, DRUG 
690 1 0 |a FEMALE 
690 1 0 |a HERPESVIRUS 1, HUMAN 
690 1 0 |a HERPESVIRUS 2, HUMAN 
690 1 0 |a KERATITIS, HERPETIC 
690 1 0 |a MACROPHAGE ACTIVATION 
690 1 0 |a MACROPHAGES, PERITONEAL 
690 1 0 |a MICE 
690 1 0 |a MICE, INBRED BALB C 
690 1 0 |a NITRIC OXIDE 
690 1 0 |a NITRITES 
690 1 0 |a OMEGA-N-METHYLARGININE 
690 1 0 |a VERO CELLS 
690 1 0 |a VIRUS REPLICATION 
700 1 |a Courreges, M.C. 
773 0 |d 1999  |g v. 98  |h pp. 363-370  |k n. 3  |p Immunology  |x 00192805  |w (AR-BaUEN)CENRE-2715  |t Immunology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032720135&doi=10.1046%2fj.1365-2567.1999.00864.x&partnerID=40&md5=b82aafb775d49cbdac3fd208930cf26b  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1046/j.1365-2567.1999.00864.x  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00192805_v98_n3_p363_Benencia  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00192805_v98_n3_p363_Benencia  |y Registro en la Biblioteca Digital 
961 |a paper_00192805_v98_n3_p363_Benencia  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 80433